Psoriasis Treatment Market 2018-2026 - Industry Applications, Market Share, Segmentation Estimated By Global Players Glenmark Pharmaceuticals Limited,Sun Pharmaceuticals Industries Ltd.,Cipla Ltd.,Johnson & Johnson
For In depth Information Get Sample Copy of this Report at: https://bit.ly/2IOha3w
There are five main types of psoriasis namely Plaque, Guttate, Inverse, Pustular, and Erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, is the most prevalent type of psoriasis, accounting for around 90% of reported cases. Most commonly affected areas of the body include back of the forearms, shins, around the navel, and the scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis is characterized by the presence of small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash become widespread and can develop from other types. Fingernails and toenails are affected in most people at some point of time. This may include pits in the nails or changes in nail color.
Global Key Players:
Key players involved in psoriasis treatment market:
Glenmark Pharmaceuticals Limited,Sun Pharmaceuticals Industries Ltd.,Cipla Ltd.,Johnson & Johnson,Rowan Bioceuticals Private Limited,Stiefel Laboratories Inc. (GlaxoSmithKline plc),Win Medicare Pvt. Ltd.,Novartis AG.
Increasing Prevalence Of Psoriasis Coupled With Early Diagnosis To Propel Growth Of Psoriasis Treatment Market:
The growth of psoriasis treatment market is projected to gain traction in North America owing to large patient pool in this region. Also, better medical facilities, commercialization of new diagnostic technology, medical policies, and favorable reimbursement policies are factors fueling growth of psoriasis treatment market. According to the International Federation of Psoriasis Associations (IFPA), around 3% of the world’s population has some form of psoriasis. According to a study published in Cleveland Clinic in September 2013, there are around 150,000 new cases of psoriasis reported each year in the U.S.
According to a study published in Medical Journal of Malaysia, in 2015 prevalence of psoriasis varies between 2.0% to 3.0% worldwide. Incidence rate is highest among Caucasians and lowest among Japanese and Africans. The study states that prevalence rate of psoriasis in Japan is 0.05% to 0.1%, as compared to China 0.5% and Taiwan 0.2%, and in India, the prevalence of psoriasis was reported in the range of 0.4% to 2.8%. High prevalence and increasing incidence propels growth of the psoriasis treatment market.
Browse Research Report At: https://bit.ly/2XngpBw
Treatment Options For Psoriasis Fueling Growth Of The Psoriasis Treatment Market:
Various treatments can help control the symptoms fueling growth of psoriasis treatment market. These treatment methods include administering steroid, vitamin D3, exposure to ultraviolet B (UVB) light, and immunosuppressive like methotrexate. Around 75% of cases can be managed with creams alone. Cream and ointments of corticosteroid, and calcipotriol can effectively treat mild-to-moderate psoriasis. However, when condition become more severe, creams are combined with oral medications such as methotrexate, acitretin, and cyclosporin.
Topical drugs used in treatment of psoriasis include corticosteroids, vitamin D, hydroxyanthrone, and retinoid aiding in growth of the psoriasis treatment market. Topical corticosteroids are frequently prescribed for treating mild-to-moderate psoriasis. Low-potency corticosteroid ointments are recommended for sensitive areas such as face or skin folds and for treating widespread patches of damaged skin. Medicated foams and scalp solutions are available in market to treat psoriasis patches on the scalp. Vitamin D analogues are synthetic forms of vitamin D and they slow the growth of skin cells. Calcipotriene (Dovonex) is a cream or solution a vitamin D that contains analogue, used by itself to treat mild-to-moderate psoriasis or in combination with other topical medications. Anthralin (Hydroxyanthrone) is used to normalize DNA activity in skin cells. Anthralin (Dritho-Scalp) also can remove scale, making the skin smoother. Topical retinoids normalizes DNA activity in skin cells and decreases inflammation.
Ask For Discount Before Purchasing This Business Report @ https://bit.ly/2H1x2Ns
Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at email@example.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Treatment Market 2018-2026 - Industry Applications, Market Share, Segmentation Estimated By Global Players Glenmark Pharmaceuticals Limited,Sun Pharmaceuticals Industries Ltd.,Cipla Ltd.,Johnson & Johnson here
News-ID: 1647211 • Views: 206
More Releases from coherenet market insights
Viscosupplementation Market - Substantial Rise in Industrial Sectors to Offer Gr …
The “Global Viscosupplementation Market Growth To Increase Manifold By 2026” A fundamental outline of the Viscosupplementation Market niche is presented by the Viscosupplementation Market report that entails definitions, classifications, applications together with an industry chain framework. The Viscosupplementation Market report is an investigative study of the market, along with an analysis of its key segments. The report is constructed through a thorough primary and secondary research. The insightful data of the
Prefilled Syringes Market Research Scope Industry Chain Analysis & Opportunities …
The “Prefilled Syringes Market” Research Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. Delivery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe. The report proves to be indispensable when
Collagen Meniscus Implant Market Research Report 2026 By Industry Size and Share …
Collagen meniscus implant is majorly indicated in multiple conditions such as loss of meniscus tissue, meniscus tears requiring partial meniscectomy, traumatic or chronic post traumatic meniscus tear, and meniscus damage requiring greater than 25% removal of meniscus. Increasing demand for specialized orthopedic clinics for the treatment of meniscus tear in emerging and developed regions is expected to drive growth of the collagen meniscus implant market during the forecast period. For
Pain Management Market Research Report 2026 By Industry Size and Shares, Feature …
Postoperative pain includes all type of acute pain that occurs due to injuries and can resolve in appropriate healing period. Such pain often responds to analgesic medication and treatment of the precipitating cause. Postoperative pain can also cause cardiovascular, respiratory, endocrine, metabolic etc. The aim of any postoperative pain treatment is to mobilize the patient as early as possible. It allows the patient to drink and eat as early as
More Releases for Psoriasis
Psoriasis Treatment Market - Innovations & Future Market Trends
Psoriasis is non-communicable autoimmune inflammatory, chronic, and painful skin disease characterized by abnormal skin patches. These skin patches are scaly, red, and itchy. These patches may be small and either localized or encompass the entire body. At present, there is no cure for this disease and the major goal of treatment is to limit inflammation and formation of abnormal skin plaque. Factors such as rising disease prevalence, significant unmet
Latest pipeline Psoriasis Market Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H2 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up skin, itchiness, and burning sensation, swollen and stiff joints. Predisposing factors include heredity, side effects of certain medicines, stress, infections and environmental conditions. The
Global Psoriasis Industrial and Market Analysis with Focus on Plaque Psoriasis: …
"Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed
Psoriasis Treatment Market: Analysis & Trends 2024
Global Psoriasis Treatment Market - Overview This report on the Psoriasis Treatment market analyzes the current and future scenario of the global market. Approval of new biologics, increase in access for the treatment in developing market, increase in the number of psoriasis patients, are boosting the growth of the global Psoriasis Treatment market. Increase in the incidence of Psoriasis and skin disorders, and novel pipeline drugs are some of the factors
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape. Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It